Neurocrine Biosciences Settles Patent Litigation Over IngrezzaBy topmanagerOctober 6, 20230 Neurocrine Biosciences, a leading biopharmaceutical company, has recently announced a settlement in the patent litigation concerning Ingrezza, their flagship product…
